Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jagruti B. Prajapati"'
Publikováno v:
Journal of Inorganic and Organometallic Polymers and Materials. 33:625-635
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8358dbe776724dde8b706202deba47e2
https://doi.org/10.1007/s10904-022-02530-7
https://doi.org/10.1007/s10904-022-02530-7
Autor:
Jagruti B. Prajapati, Gayatri Patel
Publikováno v:
INDIAN DRUGS. 58:61-67
Rotigotine (RTG) loaded Nanostructure Lipid Carriers (NLCs) were developed for the treatment of Parkinson’s disease. To estimate RTG entrapped in NLCs, UV spectrophotometric method was developed and validated. The solvent and wavelength of detectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbe8d2cae967285b51ea6e1104f07e85
https://doi.org/10.53879/id.58.08.12205
https://doi.org/10.53879/id.58.08.12205
Publikováno v:
Journal of Drug Delivery Science and Technology. 43:318-326
Isradipine (ISR), BCS Class II antihypertensive drug undergoes extensive first pass metabolism (FPM) with low bioavailability (15–24%). FPM may be avoided by formulating ISR loaded Solid Lipid Nanoparticles (SLN). Lipidic ISR-SLN get absorbed throu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abeb69503fcd3d5a36520c45f19c5cb9
https://doi.org/10.1016/j.jddst.2017.10.017
https://doi.org/10.1016/j.jddst.2017.10.017
Publikováno v:
Scopus-Elsevier
The objective of work was to develop and validate a UV spectrophotometric method for determination of agomelatine (AGM) loaded in nanostructured lipid carriers (NLCs). The solvent and wavelength of detection were optimized in order to maximize sensit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::848c32a1babd17a5e9044f2597526fcd
https://doi.org/10.53879/id.54.03.10663
https://doi.org/10.53879/id.54.03.10663
Autor:
Gayatri Patel, Jagruti B. Prajapati
Publikováno v:
Journal of Drug Delivery Science and Technology. 63:102377
Rotigotine (RTG), for the treatment of Parkinson disease has low oral bioavailability (1–5%) due to its high gut clearance and restricted entry by brain barriers.RTG is dopamine (D1-D5) &5HT1A agonist and α-2 adrenergic receptors antagonist. In pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a18a9b9d7dd93fc3d67ef75c1e044be
https://doi.org/10.1016/j.jddst.2021.102377
https://doi.org/10.1016/j.jddst.2021.102377
Publikováno v:
Drug metabolism letters. 13(2)
Background: Many CNS drugs have low bioavailability due to their poor water solubility of extensive first-pass metabolism and hence have less effectiveness. Objective: The present study aims to enhance the solubility and oral bioavailability of poorl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff093fa8479125beaa9ba5bf6dd9d65c
https://pubmed.ncbi.nlm.nih.gov/31975684
https://pubmed.ncbi.nlm.nih.gov/31975684
Publikováno v:
International Journal of Nanomedicine
Jagruti B Prajapati, Sneha D Verma, Amit A Patel Department of Ppharmaceutics and Ppharmaceutical Technology, Rramanbhai Patel College of Ppharmacy, Charotar University of Science and Technology, Changa, Gujarat, India Abstract: Agomelatine (AGM) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::222ae454678ffb4124bda88e68d51c92
https://www.dovepress.com/oral-bioavailability-enhancement-of-agomelatine-by-loading-into-nanost-peer-reviewed-article-IJN
https://www.dovepress.com/oral-bioavailability-enhancement-of-agomelatine-by-loading-into-nanost-peer-reviewed-article-IJN
Publikováno v:
Journal of Pharmaceutics and Drug Development. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94cf95e9e8b41405a6e77e98ee49441b
https://doi.org/10.15744/2348-9782.2.101
https://doi.org/10.15744/2348-9782.2.101